Modification of aortic contractility in the cardiomyopathic hamster

British Journal of Pharmacology

Volumn 118, Issue 5, 1996, Pages 1141-1146

  Dumont, Eric C ^a   Lambert, Chantal ^a   Lamontagne, Daniel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

5 hydroxytryptamine; Angiotensin II; Aortic rings; Ca2+; Cardiomyopathic hamsters; Contractility; G proteins; Phenylephrine; PKC

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; CALCIUM ION; PHENYLEPHRINE; PHORBOL 13 ACETATE 12 MYRISTATE; POTASSIUM CHLORIDE; PROTEIN KINASE C; SEROTONIN;

ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HAMSTER; MALE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; THORACIC AORTA; VASCULAR ENDOTHELIUM;

EID: 0030037435     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15516.x     Document Type: Article

References (46)

1. BAJUSZ, E. (1969). Hereditary cardiomyopathy: a new disease model. Am. Heart J., 77, 686-696.
2. BERRIDGE, M.J. & IRVINE, R.F. (1984). Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 312, 315-321.
3. BIGAY, J., DETERRE, P., PFISTER, C. & CHABRE, M. (1985). Fluoroaluminates activate transducin-GDP by mimicking the gamma-phosphate of GTP in its binding site. FEBS Lett., 191, 181-185.
4. BIGAY, J., DETERRE, P., PFISTER, C. & CHABRE, M. (1987). Fluoride complexes of aluminium or beryllium act on G-proteins as reversibly bound analogues of the gamma phosphate of GTP. EMBO J., 6, 2907-2913.
5. BÖHM, M., MENDE, U., SCHMITZ, W. & SCHOLZ, H. (1986). Increased responsiveness to stimulation of α- but not β-adrenoceptors in the hereditary cardiomyopathy of the Syrian hamster. Intact adenosine- and cholinoceptor-mediated isoprenaline antagonistic effect. Eur. J. Pharmacol., 128, 195-203.
6. CARBONE, A., MINIERI, M., SAMPAOLESI, M., FIACCAVENTO, R., DE FEO, A., CESARONI, P., PERUZZI, G. & DI NARDO, P. (1995). Hamster cardiomyocytes: a model of myocardial regeneration. Ann. N. Y. Acad. Sci., 752, 65-71.
7. CHEMLA, D., SCALBERT, E., DESCHÉ, P. & LECARPENTIER, Y. (1991). La cardiomyopathie du hamster Syrien. Aspects physiopathologiques et thérapeutiques. Arch. Mal. Coeur., 84, 85-87.
8. CHOPRA, L.C., TWORT, C.H.C. & WARD, J.P.T. (1994). Differences in sensitivity to the specific protein kinase C inhibitor Ro31-8220 between small and large bronchioles of the rat. Br. J. Pharmacol., 113, 1237-1242.
9. DE LÉAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
10. DUMONT, E. & LAMONTAGNE, D. (1995). No role of ATP-sensitive potassium channels in the vasoconstriction produced by vasopressin. J. Vasc. Res., 32, 138-142.
11. FACTOR, S.M., MINASE, T., CHO, S., DOMINITZ, R. & SONNENBLICK, E (1982). Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation, 66, 342-354.
12. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
13. HOULD, R. (1984). Techniques d'Histopathologie et de Cytopathologie, pp. 19-383, Montréal: Décarie éditeur.
14. HUNTER, E.G. & ELBRINK, J. (1982). Increased contractility in vascular smooth muscle of dystrophic hamsters. Can. J. Physiol. Pharmacol., 61, 182-185.
15. HUNTER, E.G., HUGHES, V. & WHITE, J. (1984). Cardiomyopathic hamsters, CHF 146 and CHF 147: a preliminary study. Can. J. Physiol. Pharmacol, 62, 1423-1428.
16. IKEBE, M., HARTSHORNE, D.J. & ELZINGA, M. (1987). Phosphorylation of the 20,000-dalton light chain of smooth muscle myosin by the calcium-activated phospholipid-dependent protein kinase. Phosphorylation sites and effects of phosphorylation. J. Biol. Chem., 262, 9569-9573.
17. JASMIN, G. & EU, H.Y. (1979). Cardiomyopathy of hamster dystrophy. Ann. N.Y. Acad. Sci., 317, 46-58.
18. JASMIN, G. & PROSCHEK, L (1982). Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line. Muscle Nerve, 5, 20-25.
19. JASMIN, G. & PROSCHEK, L. (1984). Calcium and myocardial cell injury. An appraisal in the cardiomyopathic hamster. Can. J. Physiol. Pharmacol., 62, 891-898.
20. KÄHÖNEN, M., ARVOLA, P., WU, X. & PÖRSTI, I (1994). Arterial contractions induced by cumulative addition of calcium in hypertensive and normotensive rats: influence of endothelium. Naunyn Schmiedeberg's. Arch. Pharmacol., 349, 627-636.
21. KAISER, L., SPICKARD, R.C. & OLIVIER, N.B. (1989). Heart failure depresses endothelium-dependent responses in canine femoral artery. Am. J. Physiol., 256, H962-H967.
22. KARLINGER, J.S., ALABASTER, C., STEPHENS, H., BARNES, P. & DOLLERY, C. (1981). Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding. Cardiovasc. Res., 15, 296-304.
23. KAWAGUCHI, H., SANO, H., KUDO, T., OKADA, H & KITABATAKE, A. (1994). Inositolphosphatides metabolism in the cardiomyopathic hamster. In The Cardiomyopathic Heart. ed. Nagano, M., Takeda, N. & Dhalla, N.S. pp. 105-114. New York: Raven Press.
24. 1 receptors in congenital cardiomyopathic hamsters. Circ. Res., 77, 1001-1007.
25. LAMBERT, C., MASSILLON, Y. & MELOCHE, S. (1995b). Reninangiotensin system and the congenital cardiomyopathic hamster. In Mechanisms of Heart Failure, ed. Singal, P.S., Dixon, I.M.C., Beamish, R.E. & Dhalla, N.S. pp. 203-214. Kluwer Academic Publishers: Boston, Dordrecht, London.
26. LIU, S.-K. & TILLEY, L.P. (1980). Animal models of primary myocardial diseases. Yale J. Biol. Med., 53, 191-211.
27. MACLEOD, K.M. & MCNEILL, J.H. (1985). The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can. J. Physiol. Pharmacol., 63, 52-57.
28. 2+ exchange during the development of genetically determined cardiomyopathy. Biochem. Biophys. Res. Commun., 133, 491-497.
29. MAYHAN, W.G. & RUBINSTEIN, I. (1992). Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamster: reversal by L-arginine. Biochem. Biophys. Res. Commun., 184, 1372-1377.
30. MOUSSA, I.S & CARTILIER, L.H. (1996). Characterization of moving fronts in cross-linked amylose matrices by image analysis. J. Control Release, (in press).
31. NISHIZUKA, Y. (1984). The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, 308, 693-698.
32. OKUMURA, K., YOSHINO, M., IWAMA, Y., TOKI, Y., MIYAZAKI, Y., HASHIMOTO, H., ITO, T. & KITOH, J. (1994). Alteration of 1,2-diacylglycerol content in myopathic hamster hearts during the development of cardiomyopathy and heart failure. In The Cardiomyopathic Heart, ed. Nagano, M., Takeda, N. & Dhalla, N.S. pp. 115-123. New York: Raven Press.
33. OLBRICH, H.-G., BORGERS, M., THONÉ, F., FROTSCHER, M., MUTSCHLER, E., SCHNEIDER, M., KOBER, G. & KALTENBACH, M. (1988). Ultrastructural localization of calcium in the myocardium of cardiomyopathic Syrian hamsters. J. Mol. Cell. Cardiol., 20, 753-762.
34. PROSCHEK, L., & JASMIN, G. (1982). Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic changes in relation to defective mitochondrial function. Muscle Nerve. 5, 26-32.
35. 3H]-forskolin binding sites in the hearts of cardiomyopathic Bio 14.6 Syrian hamsters. In The Cardiomyopathic Heart. ed. Nagano, M., Takeda, N. & Dhalla, N.S. pp87-94. New York: Raven Press.
36. SCHLENKER, E.H. & BURBACH, J.A. (1990). Structure and function of the respiratory system of the dystrophic hamster. Lung, 168, 125-136.
37. SETHI, R., PANAGIA, V., DHALLA, K.S., BEAMISH, R.E., JASMIN, G. & DHALLA, N.S. (1994). Status of β-adrenergic mechanisms during the development of congestive heart failure in cardiomyopathic hamsters (UM-X7.1). In The Cardiomyopathic Heart, ed. Nagano, M., Takeda, N. & Dhalla, N.S. pp. 73-86. New York: Raven Press.
38. SOLE, M.J. & LIEW, C.-C. (1988). Catecholamines, calcium and cardiomyopathy. Am. J. Cardiol., 62, 20G-24G.
39. SONNENBLICK, E.H., FEIN, F., CAPASSO, J.M. & FACTOR, S.M. (1985). Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. Am. J. Cardiol., 55, 179B-184B.
40. STROBECK, J.E., FACTOR, S.M., BHAN, A. SOLE, M., LIEW, C.C., FEIN, F. & SONNENBLICK, E.H. (1979). Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical, and structural features. Ann. N.Y. Acad. Sci., 317, 59-88.
41. + ATPase gene expression in the cardiomyopathic heart. In The Cardiomyopathic Heart. ed. Nagano, M., Takeda, N. & Dhalla, N.S. pp. 15-21. New York: Raven Press.
42. VER DONCK, L., VERELLEN, G., GEERTS, H., OLBRICH, H -G., MUTSCHLER, E. & BORGERS, M. (1994). Altered contractile behavior of cardiomyocytes from cardiomyopathic hamsters. In The Cardiomyopathic Heart. ed. Nagano, M., Takeda, N. & Dhalla, N.S. pp. 49-55. New York: Raven Press.
43. WALSH, M.P. (1994). Regulation of vascular smooth muscle tone. Can. J. Physiol. Pharmacol., 72, 919-936.
44. WALSH, M.P., ANDREA, J.E., ALLEN, B.G., CLÉMENT-CHOMIENNE, O., COLLINS, E.M. & MORGAN, K.G. (1994). Smooth muscle protein kinase C. Can. J. Physiol. Pharmacol., 72, 1392-1399.
45. WARD, J.P.T. & CAMERON, I.R. (1984). Adaptation of the cardiac muscle sodium pump to chronic potassium deficiency. Cardiovasc. Res., 18, 257-263.
46. WEISMAN, H.F. (1993). The role of calcium channel abnormalities in Syrian hamster cardiomyopathy. Clin. Immunol. Immunopathol., 68, 170-174.